Lord, Abbett & Co
CLVS

Lord, Abbett & Co’s Clovis Oncology, Inc. CLVS Stock Holding History

Lord, Abbett & Co’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-193,117
Closed -$13.1M – 922
2017
Q4 		$13.1M Sell
193,117
-91,448
-32% -$6.39M 0.04% 580
2017
Q3 		$23.4M Sell
284,565
-294,832
-51% -$23.4M 0.07% 429
2017
Q2 		$54.2M Sell
579,397
-24,760
-4% -$1.52M 0.16% 193
2017
Q1 		$38.5M Buy
604,157
+404,784
+203% +$24.6M 0.12% 279
2016
Q4 		$8.86M Buy
199,373
+69,519
+54% +$2.45M 0.03% 615
2016
Q3 		$4.68M Buy
+129,854
New +$2.79M 0.01% 748
2015
Q4 		– Sell
-233,469
Closed -$21.5M – 969
2015
Q3 		$21.5M Sell
233,469
-580,659
-71% -$50.3M 0.06% 403
2015
Q2 		$71.5M Buy
814,128
+243,048
+43% +$20.8M 0.19% 152
2015
Q1 		$42.4M Buy
571,080
+16,685
+3% +$1.18M 0.11% 294
2014
Q4 		$31M Buy
+554,395
New +$29.1M 0.08% 359
2014
Q3 		– Sell
-123,153
Closed -$5.1M – 1054
2014
Q2 		$5.1M Sell
123,153
-23,737
-16% -$1.22M 0.01% 796
2014
Q1 		$10.2M Sell
146,890
-246,769
-63% -$18.1M 0.02% 628
2013
Q4 		$23.7M Buy
393,659
+93,865
+31% +$5.11M 0.05% 484
2013
Q3 		$18.2M Sell
299,794
-29,647
-9% -$2.1M 0.04% 538
2013
Q2 		$22.1M Buy
+329,441
New +$14.8M 0.05% 485

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Lord, Abbett & Co's CLVS Position: Q1 2018 in Review

Lord, Abbett & Co sold out of Clovis Oncology, Inc. (CLVS) in Q1 2018, closing a stake of 193,117 shares — an estimated $13.1M sold.

Lord, Abbett & Co first reported a position in CLVS in Q2 2013 and held it in 15 quarters. The position peaked at $71.5M in Q2 2015. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2018.

  • Lord, Abbett & Co reported no remaining Clovis Oncology, Inc. position as of Q1 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 193,117 Clovis Oncology, Inc. shares in Q1 2018, an estimated $13.1M.
  • Lord, Abbett & Co first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 15 quarters.
  • Lord, Abbett & Co's Clovis Oncology, Inc. position peaked at $71.5M in Q2 2015.
  • 229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2018.

Based on Lord, Abbett & Co's 13F filing for Q1 2018, filed 15 May 2018.